At a time when the COVID-19’s second wave is still picking up in countries like India, a number of reports describe the potential association with rise in the number of cases of mucormycosis, commonly known as the black fungus. This fungal infection has been around for centuries and affects those people whose immunity has been compromised due to severe health conditions. In this article, we provide a detailed overview of mucormycosis and discuss how COVID-19 could have caused a sudden spike in an otherwise rare disease in countries like India. The article discusses the various symptoms of the disease, class of people most vulnerable to this infection, preventive measures to avoid the disease, and various treatments that exist in clinical practice and research to manage the disease.


This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution‑NonCommercial‑ShareAlike 4.0 License (https://creativecommons.org/licenses/by-nc-sa/4.0/), which allows others to remix, tweak, and build upon the work on‑commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. For reprints contact: WKHLRPMedknow_reprints@wolterskluwer.com.

Cite as

Chamola, V., Mohammadi, R., Nair, H., Goyal, A., Patel, A., Hassija, V., Bassetti, M., Narang, P., Paredes, R., Santos, J., Hashemi, S., Sani, M., Shirani, K., Alijani, N., Abtahi Naeini, B., Pourazizi, M., Abtahi, S., Khorvash, F., Khanjari, M. & Ahmadikia, K. 2022, 'COVID-19 Associated Mucormycosis: A Review of an Emergent Epidemic Fungal Infection in 3 Era of COVID-19 Pandemic', Journal of Research in Medical Sciences, 27(1), article no: 57. https://doi.org/10.4103/jrms.jrms_1090_21

Downloadable citations

Download HTML citationHTML Download BIB citationBIB Download RIS citationRIS
Last updated: 23 September 2022
Was this page helpful?